From: Metastatic colo-rectal cancer: real life experience from an Indian tertiary care center
Chemotherapy line | Oxaliplatin | Irinotecan | VEGF MoAB | EGFR MoAB | CT alone | CT + MoAB |
---|---|---|---|---|---|---|
1st (100%) n = 377 | 71% | 26% | 4.5% | 7.9% | 87.5% | 12.5% |
2nd (33%) n = 124 | 26.4% | 59% | 19% | 12.6% | 68.5% | 31.5% |
3rd (8.4%) n = 32 | 48% | 29% | 30% | 17% | 52% | 48% |